Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients

Summary

The purpose of this study is to evaluate whether vaccination with a Melan-A VLP vaccine leads to a specific cellular immune response in patients with malignant melanoma at advanced stage of the disease.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications